PFND.US Pathfinder Cell Therapy Inc

Healthcare Biotechnology USA Stocks
0.0001 USD
Close of Oct 6, 2026
0.0001 0.0001
Market cap
USD 66.7K
P/E
-
P/B
-
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2015.

Is PFND.US undervalued?

Graham number

The Graham number of Pathfinder Cell Therapy Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Pathfinder Cell Therapy Inc fundamental analysis

No fundamental analysis for Pathfinder Cell Therapy Inc yet.

Pathfinder Cell Therapy Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Pathfinder Cell Therapy Inc

Pathfinder Cell Therapy, Inc., a development stage regenerative medicine company, focuses on developing novel cell-derived and related therapies for the treatment of various diseases and medical conditions characterized by organ-specific cell damage. It identifies diabetes, renal disease, myocardial infarction, peripheral vascular disease, and other diseases as potential indications for therapies based on its technology. The company was founded in 2008 and is headquartered i…

Full company profile